Skip to content
The Policy VaultThe Policy Vault

EpogenMedica

Anemia associated with myelodysplastic syndrome

Initial criteria

  • Patient is age ≥ 18 years
  • Patient has a hemoglobin < 10.0 g/dL OR a serum erythropoietin level ≤ 500 mU/mL
  • Patient is currently receiving iron therapy OR has adequate iron stores according to the prescriber
  • Medication is prescribed by or in consultation with a hematologist or oncologist

Reauthorization criteria

  • Patient is age ≥ 18 years
  • Patient has a hemoglobin ≤ 12.0 g/dL
  • Patient is currently receiving iron therapy OR has adequate iron stores according to the prescriber
  • Medication is prescribed by or in consultation with a hematologist or oncologist

Approval duration

1 year